Cargando…
P075 Feasibility of 12 weeks melatonin supplementation in Mild Cognitive Impairment
INTRODUCTION: Melatonin has been hypothesised to slow cognitive decline in older adults due to its proposed multiple therapeutic benefits. METHODS: Participants with Mild Cognitive Impairment (MCI) were recruited from the community for a pilot 12-week randomised placebo-controlled trial of 25mg oral...
Autores principales: | Menczel Schrire, Z, Phillips, C, Duffy, S, Marshall, N, Mowszowski, L, LaMonica, H, Gordon, C, Naismith, S, Grunstein, R, Hoyos, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109307/ http://dx.doi.org/10.1093/sleepadvances/zpac029.145 |
Ejemplares similares
-
Feasibility of 3-month melatonin supplementation for brain oxidative stress and sleep in mild cognitive impairment: protocol for a randomised, placebo-controlled study
por: Menczel Schrire, Zoe, et al.
Publicado: (2021) -
P076 Safety of higher doses of melatonin in adults: A systematic review and meta-analysis
por: Menczel Schrire, Z, et al.
Publicado: (2022) -
Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults
por: Tuft, Colin, et al.
Publicado: (2023) -
P056 REducing Sleep Apnoea for the PrEvention of Dementia (REShAPED): The protocol of a multi-site feasibility randomised controlled trial
por: Hoyos, C, et al.
Publicado: (2022) -
O008 Embedding digital sleep health into primary care practice: perspectives of general practitioners, nurses, and pharmacists
por: Cheung, J, et al.
Publicado: (2021)